Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: Involvement of areas coexpressing CRF receptors and opioid peptides

Neuropsychopharmacology

Volumn 32, Issue 12, 2007, Pages 2530-2542

  Mousa, Shaaban A ^a   Bopaiah, Cheppudira P ^b   Richter, Jan F ^a   Yamdeu, Reine S ^a   Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Antinociception; Central nervous system; CRF; Inflammatory pain; Opioid peptides; Peripheral nervous system

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FREUND ADJUVANT; OPIATE PEPTIDE;

ALPHA HELIX; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG SPECIFICITY; HINDLIMB; IMMUNOHISTOCHEMISTRY; MALE; NEUROMODULATION; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; SPINAL PAIN; SUBCUTANEOUS TISSUE;

ANALGESICS; ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FREUND'S ADJUVANT; GANGLIA, SPINAL; HORMONE ANTAGONISTS; INFLAMMATION; MALE; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SCIATIC NERVE; SPINAL CORD;

EID: 35349003158     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301393     Document Type: Article

References (80)

1. Aldenhoff JB, Gruol DL, Rivier J, Vale W, Siggins GR (1983). Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221: 875-877.
2. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160: 1-12.
3. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ et al (1995). Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15: 3328-3341.
4. Ayesta FJ, Nikolarakis KE (1989). Peripheral but not intracerebroventricular corticotropin-releasing hormone (CRH) produces antinociception which is not opioid mediated. Brain Res 503: 219-224.
5. Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557 (Review).
6. Bell JA, de Souza EB (1988). Functional corticotropin-releasing factor receptors in neonatal rat spinal cord. Peptides 9: 1317-1322.
7. Besson JM, Chaouch A (1987). Peripheral and spinal mechanisms of nociception. Physiol Rev 67: 67-186.
8. Bianchi M, Panerai AE (1995). CRH and the noradrenergic system mediate the antinociceptive effect of central interleukin-la in the rat, Brain Res. Bull 36: 113-117.
9. Bianchi M, Sacerdote P, Locatelli L, Mantegazza P, Panerai AE (1991). Corticotropin releasing hormone, interleukin-1a, and tumor necrosis factor-α share characteristics of stress mediators. Brain Res 546: 139-142.
10. Bittencourt JC, Sawchenko PE (2000). Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 20: 1142-1156.
11. Britton KT, Morgan J, Rivier J, Vale W, Koob GF (1985). Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology (Berl) 86: 170-174.
12. Borsody MK, Weiss JM (1996). Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res 724: 149-168.
13. Bouckoms AJ (1994). Limbic surgery for pain. In: Wall PD, Melzack R (eds). Textbook of Pain, 3rd edn. Churchill Livingstone: Edinburgh. pp 1171-1187.
14. Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, Schafer M et al (2004). Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108: 67-75.
15. Cabot P, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler J et al (1997). Immune cell-derived b-endorphin. J Clin Investig 100: 142-148.
16. Cabot PJ, Carter L, Schäfer M, Stein C (2002). Methionine- enkephalin- and dynorphin A-release from immune cells and control of inflammatory pain. Pain 93: 207-212.
17. Calza L, Pozza M, Zanni M, Manzini CU, Manzini E, Hokfelt T (1998). Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82: 575-589.
18. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C et al (1986). Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6: 2908-2914.
19. Cui XY, Lundeberg T, Yu LC (2004). Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats. Brain Res 995: 23-28.
20. Dunn AJ, Berridge CW (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15: 71-100 (Review).
21. Ehlers CL, Henriksen SJ, Wang M, Rivier J, Vale W, Bloom FE (1983). Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rat. Brain Res 278: 332-336.
22. Frank AJ, Tilby MJ (2003). Quantification of DNA adducts in individual cells by immunofluorescence: effects of variation in DNA conformation. Exp Cell Res 283: 127-134.
23. Hargreaves KM, Dubner R, Costello AH (1989). Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol 170: 275-279.
24. Hargreaves KM, Mueller GP, Dubner R, Goldstein D, Dionne RA. (1987). Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Res 422: 154-157.
25. Gué M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L (1997). Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 9: 271-279.
26. Ikeda H, Kusudo K, Ryu PD, Murase K (2003). Effects of corticotropin-releasing factor on plasticity of optically recorded neuronal activity in the substantia gelatinosa of rat spinal cord slices. Pain 106: 197-207.
27. Ji RR, Zhang X, Wiesenfeld-Hallin Z, Hokfelt T (1994). Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci 14: 6423-6434.
28. Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ (1990). Induction of b-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759-764.
29. Kiang JG, Wei ET (1987). Corticotropin-releasing factor inhibits thermal injury. J Pharmacol Exp Ther 243: 517-520.
30. Kita A, Imano K, Nakamura H (1993). Involvement of corticotropin- releasing factor in the antinociception produced by interleukin-1 in mice. Eur J Pharmacol 237: 317-322.
31. Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY et al (2005). Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25: 3651-3660.
32. Lariviere WR, Melzack R (2000). The role of corticotropin-releasing factor in pain and analgesia. Pain 84: 1-12.
33. Lejeune F, Millan MJ (2003). The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats. Eur J Pharmacol 464: 127-133.
34. Likar R, Mousa SA, Steinkellner H, Koppert W, Philippitsch G, Stein C et al (2007). Involvement of intraarticular corticotropin-releasing hormone in postoperative pain modulation. Clin J Pain 23: 136-142.
35. Llewellyn-Smith IJ, Dicarlo SE, Collins HL, Keast JR (2005). Enkephalin-immunoreactive interneurons extensively innervate sympathetic preganglionic neurons regulating the pelvic viscera. J Comp Neurol 488: 278-289.
36. Lund I, Lundeberg T, Carleson J, Sonnerfors H, Uhrlin B, Svensson E (2006). Corticotropin releasing factor in urine - a possible biochemical marker of fibromyalgia. Responses to massage and guided relaxation. Neurosci Lett 403: 166-171.
37. McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G et al (2006). Cerebrospinal Fluid Corticotropin-Releasing Factor Concentration is Associated with Pain but not Fatigue Symptoms in Patients with Fibromyalgia. Neuropsychopharmacology 31: 2776-2782.
38. Melzack R (1999). Pain - an overview. Acta Anaesthesiol Scand 43: 880-884.
39. Melzack R, Wall PD (1996). The Challenge of Pain, Updated 2nd edn. Penguin Books: London. p 339.
40. Merchenthaler I, Vigh S, Schally AV, Stumpf WE, Arimura A (1984). Immunocytochemical localization of corticotropin releasing factor (CRF) like immunoreactivity in the thalamus of the rat. Brain Res 323: 119-122.
41. Millan MJ (1999). The induction of pain: an integrative review. Prog Neurobiol 57: 1-164 (Review).
42. Mousa SA, Bopaiah CP, Shaqura M, Fischer O, Hofmann J, Hellweg R et al (2007). Nerve growth factor increases sensory neuron μ-opioid receptors and responsiveness during inflammatory pain. Brain 130(Pt 2): 502-513.
43. Mousa SA, Bopaiah CP, Stein C, Schafer M (2003). Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106: 297-307.
44. Mousa SA, Machelska H, Schäfer M, Stein C (2002). Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126: 5-15.
45. Mousa SA, Schafer M, Mitchell WM, Hassan AH, Stein C (1996). Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 311: 221-231.
46. Mousa SA, Shakibaei M, Sitte N, Schafer M, Stein C (2004). Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145: 1331-1341.
47. Nagaraja RY, Grecksch G, Reymann KG, Schroeder H, Becker A (2004). Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits. Naunyn Schmiedebergs Arch Pharmacol 370: 26-34.
48. Nijsen M, Ongenae N, Meulemans A, Coulie B (2005). Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17: 423-432.
49. Nozu T, Kudaira M (2006). Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans. J Gastroenterol 41: 740-744.
50. Paxinos G, Watson C (1997). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York, Paperback.
51. Pavcovich LA, Valentino RJ (1997). Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. J Neurosci 17: 401-408.
52. Poree LR, Dickenson AH, Wei ET (1989). Corticotropin-releasing factor inhibits the response of trigeminal neurons to noxious heat. Brain Res 502: 349-355.
53. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K et al (1994). Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91: 8777-8781.
54. Rivier C, Rivier J, Vale W (1986). Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231: 607-609.
55. Sagami Y, Shimada Y, Tayama T, Satake M, Endo Y, Shoji T et al (2004). Effect of a corticotropin-releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53: 958-964.
56. Schäfer M, Carter L, Stein C (1994). Interleukin 1b and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91: 4219-4223.
57. Schäfer M, Mousa SA, Stein C (1997). Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol 323: 1-10.
58. Schmitt TK, Mousa SA, Brack A, Schmidt DK, Rittner HL, Welte M et al (2003). Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology 98: 195-202.
59. Schulte G, Robertson B, Fredholm BB, DeLander GE, Shortland P, Molander C (2003). Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience 121: 907-916.
60. Schwetz I, McRoberts JA, Coutinho SV, Bradesi S, Gale G, Fanselow M et al (2005). Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats. Am J Physiol Gastrointest Liver Physiol 289: G704-G712.
61. Sharp B, Linner K (1993). What do we know about the expression of proopiomelanocortin transcripts and related peptides in lymphoid tissue? Endocrinology 133: 1921A-1921B.
62. Sherman JE, Kalin NH (1987). The effects of ICV-CRH on novelty-induced behavior. Pharmacol Biochem Behav 26: 699-703.
63. Sherman JE, Kalin NH (1988). ICV-CRH alters stress-induced freezing behaviour without affecting pain sensitivity. Pharmacol Biochem Behav 30: 801-807.
64. Sibinga NE, Goldstein A (1988). Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 6: 219-249.
65. Siggins GR, Gruol D, Aldenhoff J, Pittman Q (1985). Electrophysiological actions of corticotropin-releasing factor in the central nervous system. Fed Proc 44: 237-242.
66. Skofitsch G, Insel TR, Jacobowitz DM (1985). Binding sites for corticotropin releasing factor in sensory areas of the rat hindbrain and spinal cord. Brain Res Bull 15: 519-522.
67. Song ZH, Takemori AE (1990). Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice. J Pharmacol Exp Ther 254: 363-368.
68. Song ZH, Takemori AE (1991). Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice. J Pharmacol Exp Ther 256: 909-912.
69. Spetea M, Rydelius G, Nylander I, Ahmed M, Bileviciute-Ljungar I, Lundeberg T et al (2002). Alteration in endogenous opioid systems due to chronic inflammatory pain conditions. Eur J Pharmacol 435: 245-252.
70. Stein C, Schafer M, Machelska H (2003). Attacking pain at its source: new perspectives on opioids. Nat Med 9: 1003-1008.
71. Strkson RV, Kjorsvik A, Tjolsen A, Hole K (1996). Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65: 167-172.
72. Taché Y, Martinez V, Wang L, Million M (2004). CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 141: 1321-1330.
73. Trafton JA, Abbadie C, Marek K, Basbaum AI (2000). Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci 20: 8578-8584.
74. Valentino RJ, Foote SL (1987). Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology 45: 28-36.
75. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C et al (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
76. Vit JP, Clauw DJ, Moallem T, Boudah A, Ohara PT, Jasmin L (2006). Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 121: 241-260.
77. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G et al (2004). Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 24: 8595-8605.
78. Wei ET, Kiang JG, Buchan P, Smith TW (1986). Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw. J Pharmacol Exp Ther 238: 783-787.
79. Williams Jr DW, Lipton JM, Giesecke Jr AH (1986). Influence of centrally administered peptides on ear withdrawal from heat in the rabbit. Peptides 7: 1095-1100.
80. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.